Pulmonary Embolism Scope of the Problem Massive vs Submassive Pulmonary Embolism.

Slides:



Advertisements
Similar presentations
Submassive Pulmonary Emboli: New Therapeutic Strategies
Advertisements

EKG at presentation. EKG next day Initial EKG F/u EKG.
Pulmonary Embolism and Infarction
Shortness of breath By: Tina Tarazi. Patient is a 49 year old F with PMH of NSCLC s/p chemotherapy and radiation and right frontal lobe resection in 12/2013.
Pulmonary Embolism. Introduction  Pulmonary Embolism is a complication of underlying venous thrombosis, most commonly of lower extremities and rarely.
Jomo Osborne Lung-2015 Baltimore, USA July , 2015.
Pulmonary Embolism and the Role of Echocardiograms in Management
Date of download: 6/22/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Thrombolysis for Pulmonary Embolism and Risk of All-Cause.
©2015 MFMER | slide-1 Less Lytic Ultrasound-assisted catheter-directed thrombolysis in the treatment of pulmonary embolism Brianne M. Ritchie, PharmD MBA.
Acute PE Management: How to Choose your Lytic Strategy
Deep Vein Thrombosis & Pulmonary Embolism
Recent Updates and Debates in PE Care
When Should I Utilize Aggressive Therapy for PE?
Percutanous thrombolysis of massive pulmonary embolism in an unstable post-op patient with recent epidural catheter and a prolonged cardiac arrest.
Catheter-Based Options for Treating PE
Aspiration with Thrombolysis for Massive Pulmonary Embolism
Concerns with Catheter Directed TPA for the Treatment of PEs
Fibrinolysis in intermediate risk PE
Piotr Sobieszczyk M.D. Cardiovascular Division
A.Postadzhiyan, MD, PhD St Anna University Hospital, Sofia, Bulgaria
Emerging Concepts in Heart Failure
Updates in Acute PE Treatment
New Guidelines to Prevent SCD: What You Need to Know
Current State of Hyperkalemia Management
Update on the Diagnosis and Management of CTEPH in Latin America
Optimizing Outcomes in Short Bowel Syndrome With IF
Identifying and Managing Dyspnea Associated With CTEPH
The ABCs of AF.
Does One Size Fit All in Obesity Management?
UNDERSTANDING RISK STRATIFICATION IN PAH:
NOACs in Clinical Practice: Are They All the Same?
Disclaimer. LEGAL AND POLICY CONSIDERATIONS OF NALOXONE FOR OPIOID TOXICITY REVERSAL.
Renal and Extrarenal Complications of ADPKD: Facilitating Better Patient Care.
Clinical Presentations of VTEa,b NOACs VTE Acute Treatment Trials.
Program Goal. Program Goal Current Stroke Guidelines: AHA/ASA.
Panelists. Secondary Prevention of Acute Ischemic Stroke: Can We Improve Outcomes?
Are We Closer to Personalized Medicine in MS?
CoreValve US Pivotal Trial High-Risk Arm Device and Access Routes.
TAVR and the Risk of Thrombosis
Program Goals Overview Glatiramer Acetate 3 Times a Week.
Stavros V. Konstantinides et al. JACC 2016;67:
Moderate/intermediate risk
Multidisciplinary Management of Hyperkalemia:
Current and Emerging Data in CTEPH
A Multidisciplinary Pulmonary Embolism Response Team
Case Study 56-year-old Presents With 1 Year of Worsening Dyspnea
Program Goals Overview Is NEDA a Reasonable Target?
Novel Insulin/GLP-1 Combinations: Of Interest to the Primary Care Physician?
Identifying Strategies for Improving Outcomes in Patients With CTEPH
NOAC Studies in VTE AF Studies Superior Outcomes.
Pulmonary Hypertension Updates From 2018
Gregory Piazza et al. JCIN 2015;8:
Program Goals Background: Anticoagulation in Patients With VTE.
Timing of surgery for pulmonary embolism: An evolving paradigm
Perspective on the Multidisciplinary Management of PAH
Treatment algorithm for managing chronic thromboembolic pulmonary hypertension (CTEPH), from the European Society of Cardiology/European Respiratory Society.
CTEPH in Clinical Practice
Clinical Challenges and Updates in Managing Seizure Clusters
Assessing the Burden of Hyperkalemia
The ABCs of AF.
Assessing the Burden of Hyperkalemia
VTE Treatment and Secondary Prevention VTE Treatment Trials Initial Dosing.
Clinical Comparisons in CTEPH
Gregory Piazza et al. JCIN 2015;8:
A) Annual diagnosed incidence of pulmonary embolism (PE), and b) annual full incidence of chronic thromboembolic pulmonary hypertension (CTEPH) per 100 000.
Diagnostic algorithm for chronic thromboembolic pulmonary hypertension
Care Team Collaboration for CAR T-Cell Therapy: Real-World Advice
Potential protocol for the treatment of pulmonary embolism (PE), incorporating direct oral anticoagulants (OACs). Potential protocol for the treatment.
Treatment algorithm for chronic thromboembolic pulmonary hypertension.
Treating Pulmonary Embolism Today
Presentation transcript:

Pulmonary Embolism Scope of the Problem

Massive vs Submassive Pulmonary Embolism

Submassive PE Clinical Spectrum

Novel Therapy Ultrasound Assisted Thrombolysis

Multidisciplinary Approach

RV/LV ratio Diagnostic Indicator

Communication is Key

Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

Recognizing CTEPH

Risk Stratification

When to Consider an IVC Filter

When to Consider Acute Surgical Embolectomy

Considerations When Using tPA

Ultrasound-facilitated Catheter-based Thrombolysis

Catheter Ultrasound Element

SEATTLE II Study Overview

SEATTLE II Study Outcomes

Paradigm Shift

Abbreviations

Abbreviations (cont)

References

References (cont)

References (cont)

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.